Bayer AG

58 projects, page 1 of 12
  • project . 2021 - 2024
    Funder: EC Project Code: 956146
    Overall Budget: 2,790,440 EURFunder Contribution: 2,790,440 EUR
    Open Access mandate for Publications and Research Data
    Partners: KUL, NKUA, University of Greifswald, MERCK HEALTHCARE KGAA, Bayer AG, Roche (Switzerland)

    The advanced age population (>65y) makes up ~20% of the total population in Europe, is the main carrier of chronic diseases and the major end-user group of medications. Yet, despite an ageing society, these end-users are entirely disregarded in the drug development proc...

  • project . 2019 - 2021
    Funder: EC Project Code: 871394
    Overall Budget: 499,479 EURFunder Contribution: 499,479 EUR
    Open Access mandate for Publications
    Partners: FUTURS HEALTH PRODUCTS SARL, Delft University of Technology, CEA, IMEC, Bayer AG, Siemens Healthcare GmbH, PHILIPS ELECTRONICS NEDERLAND BV, Fraunhofer

    The objective of the HELoS CSA is to support the Health.E Lighthouse Initiative Advisory Service (LIASE) in its ambition to accelerate innovation in medical devices (“Moore for Medical”). Health.E will accelerate the innovation in medical devices and systems by stimulat...

  • project . 2015 - 2019
    Funder: EC Project Code: 675251
    Overall Budget: 4,090,250 EURFunder Contribution: 4,090,250 EUR
    Open Access mandate for Publications
    Partners: DTU, BAYER TECHNOLOGY SERVICES GMBH, RWTH, Alfa Laval, Bayer AG, Unilever UK Central Resources Ltd, University of Strathclyde, Université Claude Bernard Lyon 1, Imperial

    The ModLife project is a European Training Network initiative that brings together 5 leading European universities, 4 global industrial players and 2 SMEs to undertake research and training in the area of product-process innovation, optimization monitoring and control f...

  • project . 2018 - 2022
    Funder: EC Project Code: 764698
    Overall Budget: 3,923,650 EURFunder Contribution: 3,923,650 EUR
    Open Access mandate for Publications and Research Data
    Partners: Utrecht University, UMC, University of Leeds, GERMAN CANCER RESEARCH CENTER, NUI GALWAY, MEDIMMUNE LIMITED, CNRS, Bayer AG, National University of Ireland, Maynooth, Imperial

    Health and disease are regulated, to a large extent, by our immune system. The immune system not only protects the body from infectious disease, but is involved in a number of conditions of increasing incidence and morbidity, such as diabetes, rheumatoid arthritis, infl...

  • project . 2021 - 2024
    Funder: EC Project Code: 955756
    Overall Budget: 3,475,400 EURFunder Contribution: 3,475,400 EUR
    Open Access mandate for Publications
    Partners: SDU, ASTRAZENECA AB, Roche (Switzerland), JANSSEN PHARMACEUTICA NV, Fachhochschule Nordwestschweiz, ZENTIVA, K.S., Fraunhofer, Bayer AG, NKUA, SOLVIAS AG...

    Oral drug products are preferred by hundreds of millions of patients in Europe. Yet, the challenges around formulating drugs for oral administration have increased tremendously over the last 30 years, mainly because most drugs coming through the Pharma pipeline are too ...

58 projects, page 1 of 12
Any information missing or wrong?Report an Issue